Krystal Biotech Announces Launch of Jeune, a Gene-Based Aesthetics Company, and Initial Phase 1 Safety Data for KB301 in Aesthetic Indications
Go back to Krystal Biotech Announces Launch of Jeune, a Gene-Based Aesthetics Company, and Initial Phase 1 Safety Data for KB301 in Aesthetic Indications(NASDAQ: KRYS) | Delayed: 169.91 +0.16 (0.09%) | |||||
---|---|---|---|---|---|---|
Previous Close | $169.75 | 52 Week High | $ | |||
Open | $170.90 | 52 Week Low | $ | |||
Day High | $172.44 | P/E | N/A | |||
Day Low | $168.96 | EPS | $ | |||
Volume | 102,268 |